Document is current

Article History

Received: 27 November 2024

Accepted: 28 December 2024

First Online: 28 January 2025

Declaration

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethical approval was obtained from the Ethics Committee of Tehran University of Medical Sciences in alignment with the Declaration of Helsinki (Ethical Code:IR.TUMS.IKHC.REC.1401.245). The registration code for this trial, available at the Iranian Registry of Clinical Trials, is IRCT20220908055916N1.

: Before obtaining informed consent, the study’s benefits, drawbacks, and potential risks were thoroughly explained to all participants. Each participant reviewed the consent form and signed it, confirming their understanding of the study procedures. Participation was entirely voluntary and free of charge. Participants were assured that they fully understood the study’s objectives, and the predetermined exit criteria were strictly followed. The trial would be discontinued if serious complications occurred in three participants at the injury site during the study. Throughout data collection and result reporting, patient identities and any information that could compromise their privacy were strictly protected.

: The authors declare no competing interests.